Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
The New England journal of medicine – Finn Richard S; Qin Shukui; Ikeda Masafumi; Galle Peter R; Ducreux Michel; Kim Tae-You; Kudo Masatoshi; Breder Valeriy; Merle Philippe; Kaseb Ahmed O; Li Daneng; Verret Wendy; Xu Derek-Zhen; Hernandez Sairy; Liu Juan; Huang Chen; Mulla Sohail; Wang Yulei; Lim Ho Yeong; Zhu Andrew X; Cheng Ann-Lii; (2020)
382 (20); 1894-1905